Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation

被引:5
|
作者
Atwater, Brett D. [1 ,2 ]
Li, Zhen [3 ]
Pritchard, Jessica [3 ]
Greiner, Melissa A. [3 ]
Nabutovsky, Yelena [4 ]
Hammill, Bradley G. [3 ]
机构
[1] Inova Heart & Vasc Inst, 3300 Gallows Rd, Fairfax, VA 22042 USA
[2] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC USA
[3] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA
[4] Abbott Vasc, Sunnyvale, CA USA
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2021年 / 14卷 / 08期
关键词
cardiac rehabilitation; defibrillator; implantable; exercise; heart failure; mortality; CHRONIC HEART-FAILURE; EXERCISE; HOSPITALIZATION; ASSOCIATION; MORTALITY; ICD-9-CM; DISEASE; ALERTS; ADULTS; TIME;
D O I
10.1161/CIRCOUTCOMES.120.007580
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Increased physical activity (PA) through cardiac rehabilitation (CR) improves outcomes in patients with heart failure and coronary disease, but CR referral remains infrequent. Implantable cardioverter-defibrillators (ICDs) can provide daily PA measurements to patients that may motivate them to increase PA, but it remains unclear if increased ICD measured PA is associated with improved outcomes with and without CR. Methods: This is a retrospective observational study of 41 731 Medicare beneficiaries with ICD implantation between January 1, 2014 and December 31, 2016. We linked daily ICD PA measurements and Medicare claims data to determine if increased PA is associated with a reduction in the likelihood of death or heart failure hospitalization. To determine if CR participation altered the effect of PA on outcomes, we performed two additional analyses matching CR participants and nonparticipants using propensity scores. The first match included demographics, comorbidities, and baseline PA measurements. The second match also included the change in PA measured during CR or the same time frame after ICD implant among nonparticipants. Results: The mean age was 75 (SD, 10) years, 30 182 beneficiaries (72.3%) were male, and 1324 (3%) participated in CR. Increased ICD detected PA was associated with improved survival. CR participants had a mean PA change of +9.7 (SD, 57.8) min/d, whereas nonparticipants had a mean change of -1.0 (SD, 59.7) min/d (P<0.001). After matching for demographics, comorbidities and baseline PA, CR participants had significantly lower 1- to 3-year mortality (hazard ratio, 0.76 [95% CI, 0.69-0.85], P=0.03). After additionally matching for the ICD measured change in PA during CR there were no differences in mortality with and without CR (hazard ratio, 1.00 [95% CI, 0.82-1.21], P=0.87). Every 10 minutes of increased daily PA was associated with a 1.1% reduction in all-cause mortality in both groups. Conclusions: Among Medicare beneficiaries with ICDs, small increases in PA were associated with significant reductions in all-cause mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes
    Bilchick, Kenneth C.
    Wang, Yongfei
    Curtis, Jeptha P.
    Shadman, Ramin
    Dardas, Todd F.
    Anand, Inder
    Lund, Lars H.
    Dahlstrom, Ulf
    Sartipy, Ulrik
    Levy, Wayne C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (13):
  • [32] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Al-Majed, Nawaf S.
    Ezekowitz, Justin A.
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) : 299 - 307
  • [33] Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
    Uslu, Abdulkadir
    Dogan, Cem
    Duman, Hakan
    Tanboga, Ibrahim Halil
    Askin, Lutfu
    Sevimli, Serdar
    NORTHERN CLINICS OF ISTANBUL, 2019, 6 (01) : 40 - 47
  • [34] Sexual activity in implantable cardioverter defibrillator patients included in cardiac rehabilitation
    Maria Maroto-Montero, Jose
    Maroto-de Pablo, Marta
    Starling-Duarte, Juan
    Prados-Cabiedas, Carolina
    Villahoz-Garcia, Carmen
    Cabrero-Soblechero, Lara
    Sanchez-Corbal, Marta
    Valverde-dos Anjos, Belen
    Munoz-Sanjuan, Yesica
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2018, 88 (02): : 116 - 123
  • [35] Elevated B-Type Natriuretic Peptide Is Associated With Increased In-Hospital Mortality or Cardiac Arrest in Patients Undergoing Implantable Cardioverter-Defibrillator Implantation
    Wei, Shaokui
    Loyo-Berrios, Nilsa I.
    Haigney, Mark C. P.
    Cheng, Hong
    Pinnow, Ellen E.
    Mitchell, Kristi R.
    Beachy, James H.
    Woodward, Albert M.
    Wang, Yongfei
    Curtis, Jeptha P.
    Marinac-Dabic, Danica
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (03): : 346 - U157
  • [36] Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death
    Sanghera, Rick
    Sanders, Richard
    Husby, Michael
    Bentsen, James G.
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALISTS FOR THE PRIX GALIEN USA AWARDS 2013, 2014, 1329 : 1 - 17
  • [37] Geographic Variation in Implantable Cardioverter-Defibrillator Use and Heart Failure Survival
    Epstein, Andrew J.
    Polsky, Daniel
    Yang, Feifei
    Yang, Lin
    Groeneveld, Peter W.
    MEDICAL CARE, 2012, 50 (01) : 10 - 17
  • [38] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Nawaf S. Al-Majed
    Justin A. Ezekowitz
    Current Cardiology Reports, 2012, 14 : 299 - 307
  • [39] Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction
    Chung, Da-Un
    Tauber, Johannes
    Kaiser, Lukas
    Schlichting, Andrea
    Pecha, Simon
    Sinning, Christoph
    Rexha, Enida
    Reichenspurner, Hermann
    Willems, Stephan
    Gosau, Nils
    Hakmi, Samer
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (02): : 247 - 257
  • [40] Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain
    van Rees, Johannes B.
    Borleffs, C. Jan Willem
    Thijssen, Joep
    de Bie, Mihaly K.
    van Erven, Lieselot
    Cannegieter, Suzanne C.
    Bax, Jeroen J.
    Schalij, Martin J.
    EUROPACE, 2012, 14 (01): : 66 - 73